EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Revascularization Strategies in ST-Segment Elevation Myocardial Infarction With Multivessel Disease

Felix Lindberg, Brynjölfur Mogensen, Sergio Buccheri, Fadi Jokhaji, Nils Witt, Colin Berry, Tomas Jernberg, Giovanna Sarno, Dimitrios Venetsanos, Stefan James, Felix Böhm

JACC: Cardiovascular Interventions · 2025

DOI: 10.1016/j.jcin.2025.02.017 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift JACC: Cardiovascular Interventions, 2025. Verfasst von Felix Lindberg und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden. Electronic address: felix.lindberg@ki.se. Hauptthemen laut MEDLINE: Coronary Artery Disease, Percutaneous Coronary Intervention, Practice Patterns, Physicians', ST Elevation Myocardial Infarction. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Randomized trials support angiographic and physiology-guided complete revascularization (CR) vs incomplete revascularization (IR) in ST-segment elevation myocardial infarction (STEMI) with multivessel disease (MVD). The implementation of these strategies in clinical practice is uncertain. OBJECTIVES: In patients undergoing percutaneous coronary intervention for STEMI with MVD, we assessed temporal trends in the utilization of different revascularization strategies and associated outcomes. METHODS: We included 20,131 patients from the SWEDEHEART (Swedish Web-system for Enhancement and Development of Evidence-based care in Heart disease Evaluated According to Recommended Therapies) registry who underwent primary percutaneous coronary intervention for STEMI with MVD between 2009 and 2021. Primary outcome was a composite of all-cause mortality, myocardial infarction, or unplanned revascularization, landmarked at 90 days postindex to account for staged procedures during this time. RESULTS: We observed increased adoption of CR (2009: 33% [n = 397 of 1,217]; 2015: 46% [n = 767 of 1,658]; 2021: 51% [n = 816 of 1,603]; P-trend < 0.001) and physiology-guided CR (2009: 0% [n = 0 of 1,217]; 2015: 7% [n = 119 of 1,658]; 2021: 14% [n = 218 of 1,603]; P-trend < 0.001). Over a median follow-up of 4.2 years (Q1-Q3: 1.8-7.1 years), the adjusted risk of a primary event was lower with angiographic CR vs IR (adjusted HR [aHR]: 0.84, 95% CI: 0.79-0.89) and physiology-guided CR vs IR (aHR: 0.80, 95% CI: 0.69-0.93) but not physiology-guided CR vs angiographic CR (aHR: 0.94, 95% CI: 0.80-1.11). CONCLUSIONS: In patients with STEMI and MVD, the implementation of CR and physiology-guided procedures increased over time. As of 2021, 51% of patients underwent CR and 14% physiology-guided CR. CR, whether angiographically or physiology guided, was independently associated with favorable outcomes, including mortality.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Coronary Artery DiseasePercutaneous Coronary InterventionPractice Patterns, Physicians'ST Elevation Myocardial InfarctionAgedFemaleHumansMaleMiddle AgedCoronary AngiographyRegistriesRisk AssessmentRisk FactorsTime FactorsTreatment Outcome

Stichwörter der Autor:innen

STEMIcomplete revascularizationfractional flow reservemultivessel disease

Autor:innen und Institutionen

  • Division of Cardiology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden. Electronic address: felix.lindberg@ki.se.
  • Department of Clinical Sciences, Danderyd University Hospital, Karolinska Institutet, Stockholm, Sweden.
  • Department of Medical Sciences, Cardiology, Uppsala University, Uppsala, Sweden; Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden.
  • Unit of Cardiology, Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Stockholm, Sweden.
  • School of Cardiovascular and Metabolic Health, Golden Jubilee National Hospital, University of Glasgow, United Kingdom.
  • Division of Cardiology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden; Heart, Vascular and Neurology Theme, Karolinska University Hospital, Stockholm, Sweden.

Zitieren

APA

Lindberg, F., Mogensen, B., Buccheri, S., Jokhaji, F., Witt, N., Berry, C., Jernberg, T., Sarno, G., Venetsanos, D., James, S., & Böhm, F. (2025). Revascularization Strategies in ST-Segment Elevation Myocardial Infarction With Multivessel Disease. JACC: Cardiovascular Interventions. https://doi.org/10.1016/j.jcin.2025.02.017

Vancouver

Lindberg F, Mogensen B, Buccheri S, Jokhaji F, Witt N, Berry C, et al. Revascularization Strategies in ST-Segment Elevation Myocardial Infarction With Multivessel Disease. JACC: Cardiovascular Interventions. 2025. doi:10.1016/j.jcin.2025.02.017

BibTeX
@article{Lindberg2025,
  author = {Lindberg, Felix and Mogensen, Brynjölfur and Buccheri, Sergio and Jokhaji, Fadi and Witt, Nils and Berry, Colin and Jernberg, Tomas and Sarno, Giovanna and Venetsanos, Dimitrios and James, Stefan and Böhm, Felix},
  title = {Revascularization Strategies in ST-Segment Elevation Myocardial Infarction With Multivessel Disease},
  journal = {JACC: Cardiovascular Interventions},
  year = {2025},
  doi = {10.1016/j.jcin.2025.02.017}
}
Kostenlos starten →